Mortensen, U M <br/><br/>
Effect of the oral hypoglycaemic sulphonylurea glibenclamide, a blocker of ATP-sensitive potassium channels, on walking distance in patients with intermittent claudication.  [electronic resource] 

 -  Diabetic medicine : a journal of the British Diabetic Association  Mar 2006 
 - 327-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0742-3071 
<br/><br/><label>Standard No.: </label>10.1111/j.1464-5491.2006.01797.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphate--metabolism<br/>Administration, Oral<br/>Aged<br/>Blood Glucose--analysis<br/>Blood Pressure--physiology<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Exercise Test<br/>Female<br/>Glyburide--administration & dosage<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Insulin--blood<br/>Intermittent Claudication--physiopathology<br/>Male<br/>Middle Aged<br/>Pain--physiopathology<br/>Potassium--blood<br/>Potassium Channel Blockers--administration & dosage<br/>Serum Albumin--analysis<br/>Walking